Editors’ Note on Revision of the Staging System for Lung Cancer
Editors’ Note on Revision of the Staging System for Lung Cancer Joseph LoCicero III MD Carolyn E. Reed MD Richard H. Feins MD Thomas W. Shields MD At the time…
Lung Tumors in the Immunocompromised Host
Lung Tumors in the Immunocompromised Host Philip G. Robinson Joseph LoCicero III Several situations may lead to the development of an immunocompromised state that could last for life or for…
Secondary Tumors of the Lung
Secondary Tumors of the Lung Mark S. Allen Joe B. Putnam Jr. Pulmonary metastases represent a particular manifestation of systemic metastases from primary malignant tumors. Although primary tumors can be…
Uncommon Primary Malignant Tumors of the Lung
Uncommon Primary Malignant Tumors of the Lung Thomas W. Shields Philip G. Robinson Most of the uncommon primary malignant tumors of the lungs are sarcomas, but they also comprise pleomorphic…
Benign Tumors of the Lung
Benign Tumors of the Lung Philip G. Robinson Thomas W. Shields Benign tumors of the lung are infrequently encountered. Martini and Beattie171 reported that <1% of the lung tumors resected…
Adenoid Cystic Carcinoma and Other Primary Salivary Gland–Type Tumors of the Lung
Adenoid Cystic Carcinoma and Other Primary Salivary Gland–Type Tumors of the Lung Richard S. D’Agostino The submucosal serous and mucous glands of the tracheobronchial tree are similar to those of…
Carcinoid Tumors
Carcinoid Tumors Juan C. Escalon Frank C. Detterbeck History Carcinoid tumors constitute a relatively uncommon group of pulmonary neoplasms, being responsible for only 0.4% to 3% of resected lung cancers.11,14,67,85,90…
Small-Cell Lung Cancer
Small-Cell Lung Cancer Thomas E. Stinchcombe Mark A. Socinski Lung cancer is the leading cause of cancer-related death among men and women in the United States, and it is estimated…
Novel Strategies for Lung Cancer Immunotherapy
Novel Strategies for Lung Cancer Immunotherapy Dominik Rüttinger Rudolf Hatz Karl-Walter Jauch Bernard A. Fox For a long time, lung cancer was not considered an immune-sensitive malignancy. For this reason…
Emerging Technologies and Techniques for the Management of Non-Small-Cell Lung Cancer
Emerging Technologies and Techniques for the Management of Non-Small-Cell Lung Cancer Ricardo S. Santos Fawad Khawaja Hiran C. Fernando Lung cancer is a significant public health problem, with approximately 215,000…
